Mylan (MYL -0.4%) says its partner Famy Care has received final FDA approval for its Abbreviated New Drug Application for Levonorgestrel and Ethinyl Estradiol Tablets, a generic version of Teva Pharmaceutical's (TEVA +0.6%) contraception product Nordette. MYL plans to begin shipping the product immediately.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Investor's Business Daily (Tue, 2:59PM)
at Investor's Business Daily (Mon, 2:59PM)
at Investor's Business Daily (Feb 2, 2015)
at Investor's Business Daily (Jan 26, 2015)
at Nasdaq.com (Jan 21, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs